Introduction
Research has begun to achieve some success in identifying genetic variants underlying heritable psychiatric disorders, yet molecular genetic studies of anxiety disorders lag behind. Wellpowered genome-wide association studies in this area are still rare, thus most of the existing knowledge is based on candidate gene studies, which have largely been inconsistent and unreplicated (Maron, Hettema, & Shlik, 2010) . One reason for this difficulty is that anxiety disorders may be genetically heterogeneous (Smoller & Tsuang, 1998) , with genetic determinants that cross diagnostic boundaries (Hettema, Neale, Myers, Prescott, & Kendler, 2006) . A possible solution is to utilize endophenotypes, intermediate phenotypes that sit in the biological pathway between genes and psychological outcomes and may be more powerful targets for gene discovery (Gottesman & Gould, 2003; Meyer-Lindenberg & Weinberger, 2006) .
The goal of the present study was to replicate previously reported candidate gene associations with anxiety disorders using hypersensitivity to carbon dioxide (CO 2 ), a well-validated endophenotype of panic disorder (PD) (Coryell, 1997) and other anxiety disorders (Caldirola, Perna, Arancio, Bertani, & Bellodi, 1997; Telch, Rosenfield, & Pai, 2012) . We examined the association between CO 2 hypersensitivity and 11 genes using both subjective and physiologic measures (respiratory rate). Subjective anxiety post-CO 2 inhalation has strong support as a heritable, panic-relevant trait marker (Battaglia et al., 2007; Coryell, Fyer, Pine, Martinez, & Arndt, 2001; Schmidt & Szolensky, 2007; Vickers, Jafarpour, Mofidi, Rafat, & Woznica, 2012) , and respiratory rate appears to be moderately heritable (h 2 = 0.51-0.62; Snieder, Boomsma, Van Doornen, & De Geus, 1997) . CO 2 response differentiates anxiety disorder patients and at-risk persons from controls (Griez, de Loof, Pols, Zandbergen, & Lousberg, 1990; Perna, Barbini, Cocchi, Bertani, & Gasperini, 1995; Rassovsky & Kushner, 2003 
Methods

Sample
Participants were 174 Caucasian students from two large, urban, public universities in Virginia (53.4% female, age: M = 19.8, SD = 2.6, range = 18-38). Participants were not screened for anxiety disorders, but completed the Anxiety Sensitivity Index (ASI; Reiss, Peterson, Gursky, & McNally, 1986) , and were selected to form approximately equal numbers across all quartiles of the score distribution. The university Institutional Review Boards approved this study and participants provided informed consent. Genetic analyses were limited to Caucasian students to control against spurious results from population stratification (Cardon & Palmer, 2003) .
Measures
We used a sustained carbon dioxide (CO 2 ) breathing task that included three phases: a 5-min baseline of breathing room air, A-C-G-C -Haplotype associated with an anxiety-neuroticism factor in females ; rs2241165 associated with PD in females (Weber et al., 2012) 
A < G 0.44 Associated with an anxiety-depression factor score in females (Hettema et al., 2008) ; increased risk for PD (Rothe et al., 2006) ; resistance to fear extinction (Lonsdorf et al., 2009) 
Associated with an anxiety-depression factor score in females (Hettema et al., 2008 ) rs4680-rs165599 G-A -Haplotype strongly associated with an anxiety-depression factor score in females (Hettema et al., 2008) Brain-derived neurotrophic factor (BDNF) rs6265 T < C 0.18 Associated with anxious depression in men (Middledorp et al., 2010) ; neuroticism (Frustaci, Pozzi, Gianfagna, Manzoli, & Boccia, 2008) ; fear extinction (Soliman et al., 2010 ) Transmembrane protein 132D (TMEM132D) rs7309727 T < C 0.28 Replicated association in a GWAS meta-analysis of PD (Erhardt et al., 2012) rs11060369
T < G 0.11 Gene associated with fear acquisition/conditioning in mice (Wemmie et al., 2004) and fear behavior in response to CO2 inhalation in mice (Ziemann et al., 2009) 
Significant association in a GWAS of PD (Gregersen et al., 2012) Corticotropin releasing hormone receptor 1 (CRHR1) rs878886 G < C 0.12 Associated with PD (Keck et al., 2008) ; fear acquisition (Heitland, Groenink, Bijlsma, Oosting, & Baas, 2013) Adenylate cyclase activating polypeptide 1 (pituitary) receptor type 1 (ADCYAP1R1) rs2267735 G < C 0.47 Associated with PTSD and impaired startle discrimination (Ressler et al., 2011) and dark-enhanced startle response (Jovanovic et al., 2013) FK506 binding protein 5 (FKBP5) rs1360780 T < C 0.30 Related to attention bias toward threat (Fani et al., 2013) and threat-related amygdala reactivity (White et al., 2012) GWAS = genome-wide association study, MAF = minor allele frequency, PD = panic disorder, PTSD = post-traumatic stress disorder. a SNP did not pass quality control in our sample.
8 min of breathing 7.5% CO 2 enriched air, and a 5 min recovery period. Breath-to-breath respiratory rate (RR), averaged across 60-s intervals, was measured continuously throughout the task via a transducer around the abdomen/chest and was recorded with a Biopac system with Acqknowledge software (Biopac Systems, Inc., Goleta, CA). Subjective anxiety was recorded at 2-min intervals throughout the task using the Subjective Units of Distress Scale (SUDS; Wolpe, 1973) , which indexes perceived anxiety on a 0-100 scale. Saliva was collected using Oragene•DISCOVER (OGR-250) Sampling Kits (DNAGenotek, Ontario, Canada). DNA was extracted per the manufacturer's protocol. Samples were genotyped on the 7900HT real-time PCR instrument using Taqman genotyping assays (Life Technologies, Grand Island, New York). Allele discrimination analysis and genotype calls were made with the ABI 7900HT Sequence Detection System (Applied Biosystems, Carlsbad, California). To verify genotyping accuracy, 10% of the samples were randomly selected for re-genotyping, with 100% concordance rates.
The 26 genotypic markers were chosen based on previously reported empirical associations with panic/anxiety disorders or related traits (see Table 1 ). Individual SNPs were selected because those SNPs demonstrated a significant phenotypic association, or tagged associated regions or genes. Markers were excluded for Hardy-Weinberg equilibrium p-values below 10 −4 (n = 0) or genotyping success below 95% (n = 2). Individuals were excluded for genotyping success below 95% (n = 2).
Data analysis
We assessed individual trajectories of physiological (RR) and subjective (SUDS) response to the CO 2 task using latent growth curve analysis in Mplus version 6 (Muthén & Muthén, 2010) . This method gives participants a score on each of the latent growth factors (intercept, slope, quadratic) that characterize the best-fitting line of their RR/SUDS level throughout the task. Linear regression (SPSS version 21) was then conducted with each SNP (minor allele count) to determine how these genetic markers predicted initial RR/SUDS (intercept), linear increase/decrease (slope), and non-linear increase/decrease (quadratic) in RR/SUDS in response to CO 2 inhalation.
Because co-localized SNPs were not independent (r = 0.08 to r = 0.81), and factor scores were also correlated (r = 0.174 to r = 0.995), we calculated the effective number of tests to correct for multiple testing (Han & Eskin, 2010; Li & Ji, 2005; Nyholt, 2004) . This resulted in an adjusted alpha level for our two phenotypic association tests of 0.0024 for RR and 0.0017 for SUDS.
Results
The trajectories of RR and SUDS response followed a quadratic pattern, with most participants experiencing a sharp increase in RR and SUDS during CO 2 administration, followed by a return to near-baseline levels in the recovery period. Table 2 presents results from the SNP regression analyses, which indicate the direction and magnitude of the association between each marker and the latent growth factors. One SNP, rs1108923, located within an intronic region of the ASIC1 gene, had a significant association with the intercept of respiratory rate. The association between the number of minor (T) alleles at this marker and RR intercept was negative (standardizedˇ= −0.27, p = 0.001), such that carriers of the T allele had lower initial RR, as illustrated in Fig. 1 . No markers met the significance threshold for association with subjective anxiety (SUDS). Additionally, female gender was predictive of higher baseline RR but was not associated with other outcome measures.
To follow up on this result, we conducted a linear regression analysis with rs1108923 predicting ASI scores. There was suggestive evidence for a negative association between the T allele and trait anxiety sensitivity (standardizedˇ= −0.18, p = 0.027). rs1108923 was also negatively, but not significantly, associated with experiencing panic during the task, including quitting the task early (n = 29, 17%; odds ratio = 0.74, p = 0.582) and panic symptoms assessed by the Diagnostic Symptoms Questionnaire (Sanderson, Rapee, & Barlow, 1989) during the baseline period (standardizeď = −0.13, p = 0.117).
Table 2
Standardized results from linear regression analyses measuring the effect of candidate genetic markers/haplotypes on latent growth factors (intercept, slope, and quadratic) underlying trajectories of response to carbon dioxide inhalation, indicated by respiratory rate (left-hand column) and subjective anxiety (right-hand column). 
Conclusions
In an attempt to validate several previously reported genetic associations with panic/anxiety using the CO 2 hypersensitivity endophenotype, we found that only one marker in the acid-sensing ion channel gene ASIC1 was associated with respiratory rate, and none with subjective anxiety response. The ASIC1 gene was negatively associated with the intercept, or initial respiratory rate, with some additional evidence for a negative association with self-reported anxiety sensitivity. Further, trait anxiety sensitivity (ASI) scores were positively correlated with baseline RR (r = 0.16, p = 0.045), indicating an interrelationship between the ASIC1 gene, anxiety sensitivity, and basal physiological anxiety, especially with respect to respiration.
Acid-sensing ion channels are responsible for detecting changes in pH in the brain (including those evoked by CO 2 ), and their abundance in the amygdala suggests a central role in interpreting chemical signals and eliciting fear behavior (Wemmie, 2011; Ziemann et al., 2009 ). The orthologous Asic1a gene directly influences the fear response in mice during a CO 2 inhalation task, due to CO 2 -induced decreases in pH (Coryell et al., 2007; Price et al., 2014; Wemmie et al., 2004; Ziemann et al., 2009) . Recent human genetic studies also found evidence for an association of ASIC1 (Smoller et al., 2014) and the related gene ASIC2 (Gregersen et al., 2012) with panic disorder.
Although ASIC1 predicted basal RR rather than CO 2 response, the physiological interrelations between respiration, CO 2 , and panic suggest further investigation of this gene's role in CO 2 response/hypersensitivity. In particular, dysfunction of the pH regulation mechanisms has been hypothesized to underlie respiratory dysregulation and the suffocation false alarm theory of PD (Maddock, 2001) , meaning that individuals with a liability to PD could have genetic differences in genes such as ASIC1 that affect pH regulation, in turn leading to basal differences in their respiratory functioning and/or anxiety levels. Our results could indicate a direct effect of ASIC1 on respiration (rather than basal physiological anxiety levels), but rodent research implies that ASIC1 does not directly affect ventilation (Ziemann et al., 2009) , at least under resting conditions (Song et al., 2012 ). That we did not see a simultaneous effect on subjective anxiety levels could be due to overall low variance in anxiety levels in our non-clinical sample, or due to the global SUDS measure's failure to capture specific relevant aspects of subjective anxiety.
Our results provided limited support for a role of any other candidate genes in the physiological or subjective anxiety response to CO 2 . Our sample was relatively small; however, power analyses indicated that we had 63-72% power to detect genetic effects accounting for 5% of the variance in the latent intercept or slope for RR/SUDS trajectories (the ASIC1 marker accounted for 7.1%) and over 80% power for the quadratic. Given the expectation of reduced phenotypic variability for well-defined endophenotypes assessed in a controlled environment, we can be more confident that our failure to detect significant effects was unlikely due to lack of power. Given the heterogeneity of, and genetic overlap between, anxiety disorders, the use of endophenotypes is a promising approach to address the current challenges in unraveling the molecular genetic basis of anxiety disorders.
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